• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Parkinson's disease: Medtronic and Eli Lilly team up on new drug delivery treatment

April 26, 2011 By drugdelivery

Medtronic

Medtronic Inc. (NYSE:MDT) is looking to bolster its position in the Parkinson’s disease market via a collaboration with Eli Lilly & Co. (NYSE:LLY) to develop a system to deliver drug therapies directly to the brain.

Under the terms of the deal, Medtronic will develop a drug pump and specially designed catheter to deliver a biologic therapy made by Lilly. The biologic, a modified form of glial cell-derived neurotrophic factor, will be consistently delivered to the brain over time by the Medtronic pump. The companies said the therapy has the potential to “impact the neuro-degeneration that leads to worsening symptoms and progression of Parkinson’s disease,” according to a prepared release.

An estimated four million to six million individuals across the globe suffer from Parkinson’s disease, according to the National Parkinson’s Foundation.

Medtronic is already heavily involved in the Parkinson’s market with its Activa DBS products, which are designed to help suppress tremors in patients suffering from the neurological disorder. Sales of the device helped boost Medtronic’s neuromodulation business by 2 percent during the three months ended Jan. 28 and 1 percent for the year to date.

Total sales for the unit amounted to $401 million for the third quarter and $1.15 billion for the nine-month period, according to regulatory filings.

The company says it has implanted DBS devices in more than 80,000 patients across the globe.

Filed Under: Drug-Device Combinations Tagged With: Eli Lilly & Co., Parkinson's disease

IN CASE YOU MISSED IT

  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS